Biosimilars are coming to the US market, that part we know, but there remain many unanswered questions: How difficult will FDA approval be? How frequently will biosimilars be prescribed? Will patients make the switch? How will biosimilars be evaluated? How will biosimilars impact healthcare costs? Read more here. (Source: Thomas Mittendorf, Jasmine Knight, Xcenda).
You are here: / / Biosimilars – They’re Coming – Are You Ready?